Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1983-07-08
1985-07-23
Moyer, Donald B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
2601225R, 424 95, A61K 3702, C07C10352
Patent
active
045308381
ABSTRACT:
CGRP (calcitonin-gene-related peptide) has the formula: ##STR1## A related peptide has the residue Lys instead of Glu in the 35-position. CGRP or this homolog or pharmaceutically acceptable salts thereof, dispersed in a pharmaceutically acceptable liquid or solid carrier, can be administered to mammals, including humans, to influence memory, mood and pain appreciation and to achieve a substantial lowering of blood pressure or gastric acid secretion over an extended period of time. They also may be administered to affect ingestion behavior, taste and sensory perception.
REFERENCES:
Amara et al., "Alternative RNA Processing . . . ", Nature, vol. 298, 15, Jul. 1982.
Amara Susan G.
Brown Marvin R.
Evans Ronald M.
Rivier Jean E. F.
Rosenfeld Michael G.
Moyer Donald B.
Stone Jacqueline M.
The Salk Institute for Biological Studies
LandOfFree
Synthetic calcitonin-gene-related peptides for lowering blood pr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic calcitonin-gene-related peptides for lowering blood pr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic calcitonin-gene-related peptides for lowering blood pr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-634180